Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
Francesco PasqualettiMario MiniatiAlessandra GonnelliGiovanni GadducciNoemi GianniniLaura PalaginiMaricia MancinoTaiusha FuentesFabiola PaiarPublished in: Biology (2023)
Despite countless papers in the field of radioresistance, researchers are still far from clearly understanding the mechanisms triggered in glioblastoma. Cancer stem cells (CSC) are important to the growth and spread of cancer, according to many studies. In addition, more recently, it has been suggested that CSCs have an impact on glioblastoma patients' prognosis, tumor aggressiveness, and treatment outcomes. In reviewing this new area of biology, we will provide a summary of the most recent research on CSCs and their role in the response to radio-chemotherapy in GB. In this review, we will examine the radiosensitivity of stem cells. Moreover, we summarize the current knowledge of the biomarkers of stemness and evaluate their potential function in the study of radiosensitivity.
Keyphrases
- cancer stem cells
- stem cells
- end stage renal disease
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- papillary thyroid
- prognostic factors
- squamous cell carcinoma
- mesenchymal stem cells
- radiation therapy
- squamous cell
- epithelial mesenchymal transition
- dna damage
- oxidative stress
- patient reported outcomes